Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Hepatitis C virus and type 1 diabetes.

Fallahi P, Di Domenicantonio A, Mazzi V, Santini F, Fabiani S, Sebastiani M, Zignego AL, Ferri C, Antonelli A.

Clin Ter. 2013;164(5):e437-44. doi: 10.7417/CT.2013.1624. Review.

PMID:
24217846
2.

Development of insulin-dependent diabetes mellitus in a patient with chronic hepatitis C during therapy with interferon-alpha.

Eibl N, Gschwantler M, Ferenci P, Eibl MM, Weiss W, Schernthaner G.

Eur J Gastroenterol Hepatol. 2001 Mar;13(3):295-8.

PMID:
11293453
3.

Autoimmune manifestations during interferon therapy in patients with chronic hepatitis C: the hepatologist's view.

Pellicano R, Smedile A, Peyre S, Astegiano M, Saracco G, Bonardi R, Rizzetto M.

Minerva Gastroenterol Dietol. 2005 Mar;51(1):55-61.

PMID:
15756146
4.

Interferon alpha and its contribution to autoimmunity.

Selmi C, Lleo A, Zuin M, Podda M, Rossaro L, Gershwin ME.

Curr Opin Investig Drugs. 2006 May;7(5):451-6. Review.

PMID:
16729722
5.

Type 1 diabetes mellitus in patients with chronic hepatitis C before and after interferon therapy.

Fabris P, Floreani A, Tositti G, Vergani D, De Lalla F, Betterle C.

Aliment Pharmacol Ther. 2003 Sep 15;18(6):549-58. Review.

6.

Induction of multiple autoantibodies to islet cell antigens during treatment with interferon alpha for chronic hepatitis C.

Wasmuth HE, Stolte C, Geier A, Gartung C, Matern S.

Gut. 2001 Oct;49(4):596-7. No abstract available.

7.

Trajectories of anti-islet autoantibodies before development of type 1 diabetes in interferon-treated hepatitis C patients. Case reports and a literature review.

Nakamura K, Kawasaki E, Abiru N, Jo O, Fukushima K, Satoh T, Kuriya G, Kobayashi M, Kuwahara H, Yamasaki H, Ide T, Eguchi K.

Endocr J. 2010;57(11):947-51. Epub 2010 Aug 26.

8.

[Autoimmune lesions of thyroid as complications of interferon treatment of chronic viral hepatitis].

Ettinger OA, Nikitin IG, Storozhakov GI.

Ter Arkh. 1999;71(12):69-72. Review. Russian. No abstract available.

PMID:
10647210
9.

Fulminant autoimmune Type 1 diabetes during interferon-alpha therapy: a case of Th1-mediated disease?

Bosi E, Minelli R, Bazzigaluppi E, Salvi M.

Diabet Med. 2001 Apr;18(4):329-32.

PMID:
11437866
10.

Hepatitis C virus infection and type 2 diabetes.

Fallahi P, Ferrari SM, Colaci M, Ruffilli I, Vita R, Azzi A, Ferri C, Antonelli A, Ferrannini E.

Clin Ter. 2013;164(5):e393-404. doi: 10.7417/CT.2013.1620. Review.

PMID:
24217842
11.

[Autoantibodies against islet cell antigens and type 1 diabetes after treatment with interferon-alpha].

Schories M, Peters T, Rasenack J, Reincke M.

Dtsch Med Wochenschr. 2004 May 14;129(20):1120-4. German.

PMID:
15143453
12.

[Extra-hepatic manifestations in the course of HCV-related chronic hepatitis: A constellation of associations].

Pellicano R.

Minerva Gastroenterol Dietol. 2000 Sep;46(3):185-91. Review. Italian. No abstract available.

PMID:
19320084
13.

Late development of diabetes mellitus after interferon-alfa and ribavirin therapy for chronic hepatitis C: a case report.

Radhakrishnan S, Upadhyay A, Mohan N, Dhar A, Walia HK, Zubaidi G.

Med Princ Pract. 2005 Jul-Aug;14(4):281-3.

14.

[Interferon therapy in chronic viral hepatitis; an autoimmunity dilemma].

Gutkowski K, Gutkowska D, Bilkiewicz T.

Przegl Lek. 2007;64(3):148-52. Review. Polish.

PMID:
17941466
15.

Autoimmunity against pancreatic islets and other tissues before and after interferon-alpha therapy in patients with hepatitis C virus chronic infection.

Betterle C, Fabris P, Zanchetta R, Pedini B, Tositti G, Bosi E, de Lalla F.

Diabetes Care. 2000 Aug;23(8):1177-81.

16.

IL-1beta, IFN-gamma and TNF-alpha increase vulnerability of pancreatic beta cells to autoimmune destruction.

Wachlin G, Augstein P, Schröder D, Kuttler B, Klöting I, Heinke P, Schmidt S.

J Autoimmun. 2003 Jun;20(4):303-12.

PMID:
12791316
17.

Glucose abnormalities in hepatitis C virus infection.

Huang JF, Yu ML, Dai CY, Chuang WL.

Kaohsiung J Med Sci. 2013 Feb;29(2):61-8. doi: 10.1016/j.kjms.2012.11.001. Epub 2012 Dec 29. Review.

18.

Cytokines and the pathogenesis of insulin-dependent diabetes mellitus.

Brouhard BH.

Cleve Clin J Med. 1992 Nov-Dec;59(6):629-33. Review.

PMID:
1424073
19.

Hepatitis C infection and diabetes.

Noto H, Raskin P.

J Diabetes Complications. 2006 Mar-Apr;20(2):113-20. Review.

PMID:
16504840
20.

A new look at viruses in type 1 diabetes.

Jun HS, Yoon JW.

Diabetes Metab Res Rev. 2003 Jan-Feb;19(1):8-31. Review.

PMID:
12592641

Supplemental Content

Support Center